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Our present knowledge of the human health effects of methylmercury exposure is derived from study
ofmajor outbreaks of human poisonings in Japan and Iraq and experimental studies on primates. Meth-
ylmercury readily passes through such physiological barriers as the blood-brain barrier, blood-testes
barrier, and the placenta. Its major pathological effects are on the nervous and reproductive systems and
the developing embryo/fetus. The neurotoxicity ofmethylmercury is well established in both humans and
non-human primates. Lesions in the cerebral and cerebellar gray matter consist of necrosis and lysis of
neurons, phagocytosis and gliosis. The changes are most prominent in the deep sulci and may have a
vascular component. A late effect is cerebral atrophy. At high dose levels the liver, kidneys, and other
organs may also have degenerative changes.
Although not yet described in humans, a major effect ofexposure offemale primates is an adverse effect
on pregnancy. Maternal female M. fascicularis blood mercury levels above 1 ppm are associated with a
decreased pregnancy rate and increased abortion rate. To date our experimental data lack sufficient
numbers to detect infrequent pregnancy effects below 1 ppm. Preliminary studies also reveal that meth-
ylmercury may also decrease the number and function (swim speed) of sperm.
Both human and primate studies demonstrate deleterious effects of methylmercury on the developing
embryo/fetus. Autopsies on human and primate infants reveal retarded brain development and the occur-
rence of a cerebral palsy-like behavior in the newborns, whereas the mother may be free of signs and
symptoms ofmethylmercury toxicity. The fetal blood level of mercury is higher than the maternal level.
Many features ofphysical and behavioral development ofthe newborn and infant have been reported from
relatively high exposure levels. Behavioral tests ofinfant primates (object permanence; visual preference)
revealed a retardation of cognitive development. Further research is needed to define the level at which
methylmercury begins to have significant neurotoxic, reproductive, or fetal developmental effects. The
increased level ofmethylmercury in somefish due to acidprecipitation andthe demonstration ofsignificant
lesions at clinically nontoxic levels suggest that the margin of safety may be narrow.
The chemical form of mercury and the dose alters the
selectionofthetarget organ(1). Forexample, inhalation
of metallic mercury (Hg0) vapor in sufficient quantity
leads to severe toxic injury to the lung alveoli and blood
vessels which, in turn, produces pulmonary edema. The
edema fluid interferes with the respiratory exchange of
oxygen and carbon dioxide. This pathological sequence
with the lung as target organ is often the result of oc-
cupational exposures and misadventure (2,3). The kid-
neys are the main target organ ofbichloride of mercury
(HgCl2). The Hg2+ ion is rapidly concentrated in the
kidneys and liver (4,5). Ifthe concentration is sufficient
it will cause necrosis of the epithelial cells lining the
kidneyproximalconvolutedtubules (6)and mayproduce
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renal failure. Although poisoning by inorganic mercu-
rials has been known since ancient times only relatively
recently has there been greater attention paid to the
organic mercury compounds. Methylmercury passes
through physiologic barriers such as the blood-brain
barrier, blood-testes barrier, and placenta with ease, in
contrast to the inorganic forms (4). Thus, methylmer-
cury is much more likely to target the nervous system,
testes and the developing embryo/fetus and will be de-
scribed in detail.
The reports of Stokes and ofJernelov at this confer-
ence presented data on the increased bioavailability of
methylmercury to fish due to acid precipitation. It now
is well established by researchers in Japan (7), Sweden
(8,9), and the United States (10-12), that bacteria in
the soil and lakes as well as in the intestinal tract (13)
can convert metallic and inorganic mercury forms to
methylmercury. Methylmercury enters the food chain
and is concentrated in fish and shellfish. The amount in
the environment ofthese creatures determines, for theMOTTET, SHAW, AND BURBACHER
main part, the amount in their tissues and thus the
amount we consume. Approximately 80% of our daily
intake of mercury is methylmercury, and the principal
sourceofmercury isseafood(14-16). Theaveragemeth-
ylmercury intake varies from 20 ,ug/day to 80 p.g/day
ormore inheavilycontaminated food (15,17,18). Clinical
and epidemiologic studies on some human subpopula-
tions with high methylmercury intake have been done
by Clarkson et al. (18-22).
Effects of Methylmercury
Three methylmercury environmental poisonings of
large populations in recent decades and some occupa-
tional reports have provided much of the clinical and
pharmacodynamic information (22-24) about the effects
of high level exposure especially as they relate to the
nervous system (25-28) and congenital injury
(21,25,26,28). However, some aspects of methylmer-
cury injury may have not come to light during these
poisonings because of limitations inherent in the field
conditions ofthe populations studied. Thus, subclinical
and low dose cases with subtle effects were less likely
to be discovered (29). The biologic differences such as
blood clearance (30-32), placental structure and func-
tion between laboratory rodents and humans has made
it necessary to use primates to uncover some of the
subtlebutimportant pathologic changes. Therefore, the
following summary of the health effects includes some
data we have derived from nonhuman primate experi-
ments to add to our understanding of the effects of
intermediate (1-2 ppm) and low (< 1 ppm) blood levels
ofmethylmercury
Neurotoxicity
That methylmercury in high doses, i.e., blood levels
above 2 ppm, is a severe neurotoxin was well estab-
lished in Japan (28), by Jalili in Iraq in 1961 (27), and
Bakir et al. in Iraq in 1972 (26). Much of the human
neuropathologywasdefined byTakeuchi(33). Thewide-
spread brain lesions lead to signs and symptoms char-
acteristically referable to that organ. They are (1) par-
asthesia, a numbness and tingling sensation around the
mouth, lips, and extremities, particularly the fingers
and toes; (2) ataxia, a clumsy stumbling gait, difficulty
in swallowing and articulating words; (3) neurasthenia,
a generalized sensation of weakness, fatigue and ina-
bility to concentrate; (4) vision and hearing loss; (5)
spasticity and tremor; and finally (6) coma and death.
Except for the briefreports ofAl-Saleem (34) and Choi
(35), scant pathologic studies have been reported from
Iraq. Neuropathologic observations reveal the cortex
of the cerebrum and cerebellum to be selectively in-
volved with focal necrosis of neurons, their lysis and
phagocytosis and replacement with supporting glial
cells (Fig. 1). These changes are most prominent in the
deeper fissures (sulci) such as in the visual cortex and
insula. The overall acute effect of these destructive
changes is cerebral edema. However, with prolonged
destruction ofgray matter and subsequent gliosis, cer-
ebral atrophy results. (Fig 2). Observations on primate
brains by Shaw (36-38), Berlin (39), and others (40) are
consistent with the above and provide atime, dose, and
tissue burden relationship. Shaw observed that in au-
topsies done more than a year after the cessation of
exposure, cerebral atherosclerosis occurred in 4 of 27
animals in small arteries and arterioles (Fig. 3.) over-
lying sites of mercury parenchymal degeneration.
Sacrifice of methylmercury-exposed monkeys that
lacked signs ofmercury poisoning (normal cage behav-
ior) revealed in a few instances neuronolysis in the cer-
ebral cortex and cerebral atrophy (ofthe type reported
in the human clinical deaths) occurred at blood mercury
levels below 2 ppm in our primates. However, our data
are incomplete to establish whether "silent damage"
occurs at lower levels.
Observations from Minamata, Japan suggest that the
lowest whole blood level ofmercury in which symptoms
had occurred was 0.2 ppm (1). However, Bakir et al.
(26) andKutsuma(27) suggestthatsymptomsmayoccur
in susceptible individuals at 0.1 ppm.
Pregnancy Outcome
The groups studying the poisonings inJapan and Iraq
have not reported data on the effects ofmethylmercury
onpregnancyoutcome. Asurprisefindinginourprimate
studies was that methylmercury decreased the preg-
nancy rate and increased the abortion rate at relatively
moderate maternal blood levels (41).
Our experimental design is as follows: Two colonies
of M. fascicularis monkeys were studied in tandem.
Each colony consisted of three groups (seven control
females received applejuice vehicle by oral administra-
tion daily; seven females received 50 ,ug MeHg/kg/day
orally in apple juice, which produced blood mercury
levels of 1.0 ± 0.13 ppm. Seven females received 90,ug
MeHg/kg daily, which produced mercury blood levels
of2.0 ± 0.33 ppm. The females were selected from our
large center which enabled us to match these groups
for parity, weight, and other standard obstetrical char-
acteristics. Half of each group was colony-born and -
reared and halfwere wild-born but colony-reared, with
a proven successful pregnancy history. One male used
in all of the experiments did not receive mercury. The
study consisted of 4 months of baseline observations
(clinical evaluation, menstrual cycles, menses, blood
chemistry, liver and kidney function tests and hemo-
gram, and blood mercury assay biweekly). Methylmer-
cury was administered on the preplanned schedule for
4 months; the animals were then mated and continued
on mercury throughout pregnancy and after. Each in-
dividual at a given dose established a blood mercury
level after 2 months of exposure which remained rela-
tively constant throughout the experiment. The mid-
menstrualcycle was established duringthebaseline and
the day of ovulation calculated (42). After 4 months of
methylmercury administration, the male was placed in
the cage with the female at ovulation for one night. If
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FIGURE 1. Primate cerebrum (occipital pole) following methylmercury exposure. Degenerating neurons (A) are accompanied by phagocytic
cells (B) and increased numbers of glial cells (C). x 100.
pregnancy did not occur, mating would be repeated for
the two subsequent cycles. If pregnancy did not occur
inthree matings it wasrecorded as nonconception. Mat-
ing, gestation (165-168 days) labor, and delivery were
recorded by video camera. After delivery the experi-
mental females were continued on methylmercury for
one year, then the study was repeated. Four ofthe first
colony of seven animals at the 90 ,ug MeHg dose level
developed slight tremor after a year of MeHg; there-
fore, the second colony high dose was reduced to 70 ,ug
MeHg/kg/day. None of the females had symptoms of
mercury intoxication during pregnancy.
To date (12/31/84), the pregnancy outcome data of29
experimental and 15 control animals are available. An
increase in nonconceptions, abortions and stillbirths is
seen at blood mercury levels above 1 ppm (Table 1). We
obtained no viable offspring above 2 ppm, but our N at
this level is too small to be statistically significant. This
type of methylmercury effect can easily be overlooked
in the human exposures. The many variables in the
FIGURE 2. Primate cerebrum late lesions following methylmercury exposure. Clusters ofglial cells surround remnants of neurons. x 100.
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FIGURE 3. Cerebral sulcus arteriole. A thick layer of intima ( T ) overlies internal elastic lamina (black layer).
Table 1. Meand Hg concentration in whole blood and
reproductive failure.
Reproductive failure' % and









aX Hg concentration during breeding and/or pregnancy.
bTotal nonconceptions, abortions, stillbirths.
'Lowest X Hg concentration for exposed females.
MeHg-exposed human populations make data of this
type difficult to derive.
Abnormal Spermatogenesis
There appears to be only one report in the literature
(43) describing decreased spermatogenesis in the hu-
mans due toalkylmercuryexposure. Lee and Dixon(44)
have shown in mice that methylmercury breaches the
blood-testes barrier much more readily than inorganic
mercury. Wehavefollowedthesereportswithaprimate
pilot studywhichiscurrentlyinprogress. Apreliminary
study by M. Mohamed in my laboratory has shown in
vitro that methylmercury at levels above 1 ppm de-
creases the motility of sperm over a 3-hr period (Fig.
4). The speed was quantitated by anew laser light scat-
termethod inmicronspersecond (45). (Invivoexposure
ofmale monkeys on a dose schedule comparable to the
above results in abnormal sperm structure (Fig. 5).
Much more remains to be done to determine whether
male fertility is decreased.
Embryopathic Effects
The fourth principal effect ofmethylmercuryis onthe
unborn child. The poisonings in Japan (28) and in Iraq
(25,26) clearly established mercury to be a human ter-
atogen in relatively high doses, with major effects on
the developing nervous system. A cerebral palsy-like
syndrome is produced. Autopsies by Takeuchi on three
fetal deaths (33) revealed a decreased number of nerve
cells in the cerebral cortex and ageneralized hypoplasia
ofthe cerebellum. The total brain weight was markedly
decreased. Choi et al. (35) autopsied two fetal brains
from Iraqi fetal deaths. High levels of brain mercury
were associated with abnormal neuron migration and
deranged organization ofbrain centers and layers were
described. At the levels and period of congenital ex-
posure, thewomeninJapanand Iraqproducedoffspring
that tended to be smaller than normal; however, many
uncontrolled variables make the human data difficult to
interpret. In laboratory rodents there is a dose-related
decrease in size/weight of the methylmercury congen-
itally exposed offspring (46,47).
We have examined the physical and behavioral de-
velopment of offspring born to primate females with
bloodlevels ofmercurybetween0.5 and 2ppmandhave
found some very interesting structural and functional
changes not reported at the lower dose levels in the
humans. At any of the given maternal mercury blood
levels within the range studied, the maternal level was
lower than the fetal (umbilical cord blood) by a ratio of
1:1.5-2.0. The data from our observations on the phys-
ical characteristics of the offspring are comparable in
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FIGURE 4. Methylinercury level and sperm speed.
expenmental and control groups-and for male and fe-
maleoffspring(Table2). There is atrend towards lower
birth weights, shorter crown-rump length, microce-
phaly, and otherphysicalparameters ofdecreased size.
However, one must be cautious in interpreting these
databecause as indicated weseparate theoffspringinto
male and female which have an inherent difference in
size in primates. We must gather further data to be
sure that maternal weight, which is an important var-
iable inbirthweight, be carefully controlled. Above the
maternalblood levelof2 ppm one sees apattern ofbrain
changes similar to that described in humans.
FIGURE 5. Primate spermatozoa following methylmercury exposure. Frequent kinking of flagella ( T ) and persistent cycoplasmic droplets (T T). Kinked areas are inflexible.MOTTET, SHAW, AND BURBACHER
Table 2. Physical characteristics of offspring at birth.a
Females Males
50,g/kg/day 50,g/kg/day
Controls (N = 6) (N = 5) Controls (N = 9) (N = 7)
Gestation, days 160 ± 2.5 157 ± 2.8 163 ± 1.5 160 ± 1.7
Birthweight, g 348 ± 21 316 ± 45 380 ± 24 344 ± 11
Crown-rump length, mm 178 ± 4 171 ± 3 181 ± 4 174 ± 3
Head width, mm 48 ± 0.8 47 ± 0.5 49 ± 0.6 49 ± 0.5
Head length, mm 61 ±0.7 59±0.7 62±0.6 61 ±0.6
Head circumference, mm 171 ± 3 164 ± 3 174 ± 2 172 ± 1
Left foot length, mm 68 ± 1 66 ± 2 70 ± 1 67 ± 1
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Task
Aoe at Criterion for Object Permanence Assessment
FIGURE 6. Primate infant object permanence test performance.
Behavioral Effects
In addition to recording the usual milestones of be-
havioral development such as the onset of reflexes,
strength of suckling, play pattern, etc., that are done
on humans and on our primate offsprings alike, some
behavioral tests have been done on these monkeys. One
of the most important findings that occurs in the off-
spring of mothers with 0.5 ppm blood level is a decre-
ment in object permanence test performances.
The object permanence test is a generally recognized
(48) milestone in cognitive development based on the
concepts developed by the late Professor Piaget (49).
Basically, in early infancy, objects that cannot be seen
do not exist until cognitive ability matures enough to
recognizethattheobjectmaystillbepresentbuthidden
behind a screen. The test is simple. Primate responses
are remarkably similarto those ofhumans. Assessment
is done with almost identical procedures.
The test is begun at 14 days of age. It was done
double-blind by Burbacher and co-workers (50). The
object is abrightly colored toy with anipple at one end.
The nipple is dipped in apple sauce and the infant in-
stinctively puts it in his mouth and sucks (the reward).
The toy is then placed on a platform within reach and
the infant grasps, picks up the toy and puts it in his
mouth (plain reach task). When the infant can accom-
plish this task four out of five times in 15 seconds, it
has reached criterion (51). Control infants achieved cri-
terion at 29 days of age, whereas the prenatally methyl-
mercury-exposed infants took 36 days ofage to achieve
criterion (Fig. 6). After criterion was achieved, the in-
fants were tested two times per week with a battery of
no hiding, partial hiding, and full hiding tasks (total 15
trials each day). There is a statistically significant re-
tardation with the prenatally mercury-exposed infants
for each task. With the full hiding task the prenatally
mercury-exposed infants reached criterion at 91 days,
whereas the controls reached criterion at 58 days.
Time does notpermitdescription ofanothercognition
test-the visual preference or Fagan Test (52,53). It is
increasingly regarded as a valid predictor ofmental re-
tardation (54). This test is based on timing the gaze to
Table 3. Primate infant visual preference test (Fagan) performance.
Control (N = 10) MeHg exposed (N = 8)
Measure Familiar Novel Familiar Novel
Percentage of looking time to novel stimuli ± SD* 67.7 ± 7.9 57.1 ± 7.3
Frequency oflooks ± SDt 4.34 ± 1.28 6.13 ± 1.81 4.43 ± 1.72 5.31 ± 2.02
Duration per look, sec + SD' 1.07 ± 0.34 1.66 ± 0.44 1.34 + 0.39 1.35 ± 0.34
*p <0.02 for groups.
tp <0.001 for stimulus type (familiar vs. novel).
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determine how quickly the offspring gazes at a novel
visual stimulus (Table 3). A decrement in the mercury-
exposed group in comparison with the controls was
found (55).
At the present time one cannot define precisely the
margin of safety between the level of methylmercury
exposure ofsome subpopulations ofpeople and the level
at whichthedevelopingembryo and fetus oradultsmay
be adversely affected. From the data presented, the
margin appears to be sufficiently narrow tobe cause for
concern and to warrant continued investigation. The
minimal exposure level at which subtle decrements in
male andfemale fertility, brainstructuralandfunctional
development and offspring growth and development oc-
cur in humans and primates awaits further investiga-
tion.
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